This is a routine, negligible Form 144 filing by a venture investor. No actionable signal for traders. Monitor for any subsequent Form 4 filings from the same insider to confirm whether the sale was executed, but the dollar amount is too small to move the stock.
Price Chart
Executive Summary
Atlas Venture Fund XII, L.P., a major venture capital shareholder of Disc Medicine (IRON), filed a Form 144 on October 19, 2026, indicating an intent to sell 115 shares of common stock. The proposed sale is de minimis in size, approximately $6,537 in value, representing a negligible fraction of the fund's likely multi-million dollar stake. This filing is a routine administrative notice by a venture investor and carries no material signal about the company's operations or outlook.
Key Facts
- Atlas Venture Fund XII, L.P. filed Form 144 to sell 115 shares of Disc Medicine common stock.
- Estimated value of the proposed sale is approximately $6,537 (based on 115 shares at a price of $56.84 per share, as stated in the filing).
- The filing is an advance notice of intent to sell, not a completed transaction.
- Atlas Venture is a venture capital fund and a significant pre-IPO/early investor in Disc Medicine.
- The sale size is immaterial relative to the fund's likely holdings and the company's market cap.
Financial Impact
Proposed sale of 115 shares valued at approximately $6,537, de minimis.
Risk Factors
- No material risk identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-066324 |
| Document: 0001628280-26-066324.txt | 0001628280-26-066324 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 2d ago | SC 13D/A | $79.90 | awaiting T+20 | awaiting T+20 | $79.90 (+0.00%) |
Oct 22, 2026 6d ago | 8-K | $74.51 | awaiting T+20 | awaiting T+20 | $79.90 (−7.23%) |
Oct 21, 2026 7d ago | 424B5 | $75.03 | awaiting T+20 | awaiting T+20 | $79.90 (−6.49%) |
Oct 21, 2026 7d ago | 144 | $75.03 | awaiting T+20 | awaiting T+20 | $79.90 (+6.49%) |
Oct 21, 2026 7d ago | 144 | $75.03 | awaiting T+20 | awaiting T+20 | $79.90 (+6.49%) |
Oct 21, 2026 7d ago | 144 | $75.03 | awaiting T+20 | awaiting T+20 | $79.90 (+6.49%) |
Oct 20, 2026 8d ago | 144 | $76.00 | awaiting T+20 | awaiting T+20 | $79.90 (+5.13%) |
Oct 20, 2026 8d ago | 144 | $76.00 | awaiting T+20 | awaiting T+20 | $79.90 (+5.13%) |
Oct 20, 2026 8d ago | 144 | $76.00 | awaiting T+20 | awaiting T+20 | $79.90 (+5.13%) |
Oct 19, 2026 9d ago | 424B5 | $79.48 | awaiting T+20 | awaiting T+20 | $79.90 (−0.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers